Technology

Sounds like a simple idea cleverly executed, which makes University of Limerick researcher Dr Michael Walsh’s claims that this new balloon angioplasty device may advance the technique sound reasonable.

Foillowing its acquisition of General Biotechnology LLC, Cook Group has announced its formation of Cook General Biotechnology LLC, in a move which will help reinforce its position in the cellular therapy field.

What an interesting deal. J&J’s Ethicon, not known for its soft negotiating stance, has agreed a deal in which it pays Angiotech for IP relating to the company’s Quill suture technology, yet is allowing the pharma company to keep on selling it.

Pluromed’s Rapid Transition Polymer™ technology finds another home in the prevention of stone migration during lithotripsy for urinary stone removal. Boston Scientific is worldwide distributor for the company’s Backstop® product.

Vasostitch looks like a clever device for accessing and then closing tissue during femoral or transapical insertion of therapeutic devices. The company pitched up at this year’s ACC, so we look forward to hearing their feedback after the event.

OrbusNeich has issued a news release about a clinical study which supports the company’s claim that its clever “pro-healing” stent technology results in a stent which can be indicated in STEMI patients.

The device fans among us are always sad to see technology companies failing to thrive and no less so this time as what looks like a promising concept in Insulin pump design isn’t enough to stave off restructuring efforts.

Guidelines are imminently to be published by the European Society of Gastrointestinal Endoscopy, which govern the use and applicability of capsule endoscopy, according to a press release from specialist company Given Imaging.

Hydrogel heal thyself. Californian researchers have taken the hydrogel to the next level with this modified version with “self-healing” characteristics.

We’ve read the release twenty times and we can get the gist… sort of. It seems that these clever people can design things that don;t use up energy on fail safe components, yet somehow end up more reliable into the bargain.

How much!? Boston Scientific must have done the maths in their decision to acquire Cameron Health and its leadless ICD device for what may end up being $1.35Bn dependent on reaching milestones over the next several years.

Covidien’s November 2011 acquisition of BARRX Medical Inc is followed now by the launch of a new dimension catheter to make treatment of Barrett’s Esophagus easier.

Christopher Lyles, the first American recipient of a seeded tracheal transplant has passed away this week.

Mobile Health will find its way into all aspects of healthcare. This nice article on e-week discusses feedback from last week’s Mobile World Congress.

Deltex Medical Group has announced that Department of Health initiatives will see wider adoption of its CardioQ Oesophageal Doppler Monitoring technology.

A great study in “teledermatology” supports a new approach to GP consultation by involving the specialist dermatologist much more close to the front line. Referrals were reduced dramatically.